SIIT has been recognized as a provincial-level new R&D institution
On December 31, 2020, the Department of Science & Technology of Shandong Province issued a notice on the announcement of the second batch of provincial new research and development institutions for the 2020. According to the "Interim Measures for the Management of New R&D Institutions in Shandong Province" and other regulations, after independent application, recommendation by prefecture and city, formal review, on-site inspection, and list disclosure,SIIT has been recognized as a provincial-level new R&D institution.
Development Plan: SIIT is established in accordance with the relevant policies of the Ministry of Science and Technology and the Department of Science and Technology on new R&D institutions. The planned area is 40000 m2, mainly including a central laboratory, engineering pilot platform, innovation service platform, enterprise incubation platform, flexible talent introduction demonstration point, standardized production workshop, etc.
Main focus: SIIT has established cooperation with 25 institutions such as medical institutions, research institutions, and enterprises, with a focus on human microecology and microbiota libraries, metabolomics, biological big data, in vitro diagnosis, and precision diagnosis and treatment. Taking the human microecology industry as the entry point, based on microbiology and metabolomics, and with the overall plan of "storage, management, and application", we will deeply explore biomedical big data, break through key core technologies of in vitro diagnosis, promote the rapid development of precision diagnosis and treatment, promote the transfer and transformation of scientific and technological achievements, connect the upstream and downstream of one health precision medical industry chain, build a recyclable transformation application system, and promote the integration of industry, academia, and research innovation.
Strategic positioning: SIIT focuses on the "two excavations, one matching, and one empowerment" of one health precision medical industry, exploring the development needs of the industry, exploring advanced scientific and technological achievements, matching industrial demand with innovative supply, re empowering old production capacity, and accelerating the transformation of new production capacity. Utilize the advantages of the collaborative innovation model of "medical research enterprise", create an engineering pilot platform cluster, incubate and cultivate technology enterprises, build flexible talent introduction demonstration points, improve the investment and financing service system of one health precision medical industry, and build a "government industry university research fund" integrated innovation mode.